Peter Fredette has well over 20 years of experience in the drug development industry, including pre-clinical toxicology and all phases of clinical research. He is most experienced in early phase oncology research but has worked across multiple therapeutic areas. Peter is well known in the industry for his experience and collaborative efforts to continually drive improvements. He is experienced in forging long-standing industry partnerships and implementing strategies to improve quality and accessibility of clinical trials for cancer patients.